Lv4
430 积分 2023-12-25 加入
Response to: Practical methods for incorporating summary time-to-event data into meta-analysis
3天前
已关闭
Response to: Practical methods for incorporating summary time-to-event data into meta-analysis
3天前
已完结
HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor–Mutated Non–Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy
4天前
已完结
Datopotamab Deruxtecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III TROPION-Lung01 Study
11天前
已关闭
TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLC
12天前
已完结
Results from a phase 1b study of telisotuzumab vedotin in combination with osimertinib in patients with c-Met protein–overexpressing, EGFR-mutated locally advanced/metastatic non-small cell lung cancer (NSCLC) after progression on prior osimertinib
12天前
已完结
A Phase 1b Study of Telisotuzumab Vedotin in Combination With Nivolumab in Patients With NSCLC
12天前
已完结
Risk of colorectal cancer associated with frequency of colorectal polyp diagnosis in relatives
1个月前
已完结
Risk of colorectal cancer associated with frequency of colorectal polyp diagnosis in relatives
2个月前
已完结
Predicting Risk of Colorectal Cancer After Adenoma Removal in a Large Community-Based Setting
2个月前
已完结
皖公网安备34019202002308
